Remember that the intellectual property #waiver proposed by the US gov only covers #COVID_19 vaccines.
It is a shame.
Here is an example why a waiver on therapeutics would be very helpful. 1/4

As outbreak rages in India, NATCO, an India-based company, has taken the risk to roll out its own generic of #baricitinib, a patent-protected drug repurposed for COVID-19. It has applied for a compulsory license, but the final decision will take time. 2/4 https://timesofindia.indiatimes.com/business/india-business/natco-rolls-out-baricitinib-ahead-of-approval-for-patent-waiver/articleshow/82442841.cms

NATCO's decision is a good decision, but a risky one from a legal standpoint. 3/4

If a waiver existed for therapeutics too, generics of on-patent COVID-19 drugs would be authorized worldwide. There'd be no need for ad hoc legal decisions like compulsory licenses. Companies would feel much more confident to swiftly produce, export & roll out generics. 4/4